Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Suritozole (MDL-26479) is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptor
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 133.00 | |
2 mg | In stock | $ 198.00 | |
5 mg | In stock | $ 297.00 | |
10 mg | In stock | $ 453.00 | |
25 mg | In stock | $ 747.00 | |
50 mg | In stock | $ 1,050.00 | |
100 mg | In stock | $ 1,420.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 267.00 |
Description | Suritozole (MDL-26479) is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptor |
In vivo | Suritozole is a negative modulator at the gamma-aminobutyric acidA (GABAA) receptor that enhances cholinergic function, in attenuating spatial memory deficits after traumatic brain injury in the rat. |
Synonyms | MDL-26479 |
Molecular Weight | 223.27 |
Formula | C10H10FN3S |
CAS No. | 110623-33-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (123.17 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Suritozole 110623-33-1 Membrane transporter/Ion channel Neuroscience GABA Receptor MDL26479 MDL-26479 MDL 26479 inhibitor inhibit